Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Technology Could Provide Ideal Drug Delivery of Cannabinoids

Pressure BioSciences’ (OTCQB: PBIO) patented technology may provide the ideal transport for CBD and other cannabinoids. The company’s novel Ultra Shear Technology (“UST) has the capacity to develop water-soluble nanoemulsions that can be employed to improve the bioavailability of cannabinoids. An article discussing the company reads: “Nanoemulsions offer an advanced mode of drug delivery that’s … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Technology Could Provide Ideal Drug Delivery of Cannabinoids”

Pressure BioSciences Inc. (PBIO) Agreement with ISS, Inc. Shows Potential to Enhance Drug Discovery and Development

The two companies entered co-marketing and distribution agreement to be implemented worldwide Pressure BioSciences’ high pressure generator technology can improve optical spectroscopy accuracy and data collection with potentially far-reaching impact on drug development The joint technology will be promoted to scientists all over the world and is expected to generate increased sales starting this year … Continue reading “Pressure BioSciences Inc. (PBIO) Agreement with ISS, Inc. Shows Potential to Enhance Drug Discovery and Development”

Pressure BioSciences Inc. (PBIO) Just Might Have the Ideal Drug Delivery Technology for Cannabinoids

The tide of cannabis legalization continues to rise Medical cannabis market on pace to hit $56 billion in seven years Company’s proprietary technology improves the bioavailability of cannabinoids With the passage of laws permitting medicinal use of cannabis in at least 32 U.S. jurisdictions and Canada, producers of cannabinoids for medical purposes are racing to … Continue reading “Pressure BioSciences Inc. (PBIO) Just Might Have the Ideal Drug Delivery Technology for Cannabinoids”

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Co-Marketing, Distribution Agreement with ISS, Inc.

Pressure BioSciences (OTCQB: PBIO) this morning said it has entered a two-year, global co-marketing and distribution agreement with ISS, Inc. The companies intend to combine the ISS high pressure optical cell with Pressure BioSciences’ automated high pressure instrument resulting in an exceptional analytical system with the potential to substantially improve biopharmaceutical drug discovery and development. … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Co-Marketing, Distribution Agreement with ISS, Inc.”

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses Recent Corporate Milestones in Webinar Update

Pressure BioSciences Inc. (OTCQB: PBIO) CEO Richard T. Schumacher earlier this week hosted a webinar update and live Q&A session for prospective investors. During the presentation, Schumacher detailed each of PBIO’s three distinct working groups, including its Research Products and Services division, its Biopharmaceutical Manufacturing division and its third group specializing in the development and … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses Recent Corporate Milestones in Webinar Update”

NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Entry into Biopharmaceutical Industry Focus of Zacks Small Cap Research Article

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the global life sciences industry, was recently the focus of a publication by Zacks Small Cap Research titled “PBIO: Enters Biopharmaceutical Quality Control Market”. The publication follows the company’s December 20 announcement regarding the release of redesigned software for its … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Entry into Biopharmaceutical Industry Focus of Zacks Small Cap Research Article”

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.

Pressure BioSciences (OTCQB: PBIO) today reported the acquisition of all assets of BaroFold, Inc. The assets acquired include all patents, equipment, and intellectual property relating to BaroFold’s PreEMT™ high-pressure protein refolding technology. A total of eight issued patents and several pending significantly enhances PBIO’s hold of intellectual property in high-pressure technologies. “In addition to the … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.”

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science

Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (OTCQB: PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science”

Pressure Biosciences, Inc. (PBIO) Starts Presentation at LD Micro Main Event

Pressure Biosciences (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating … Continue reading “Pressure Biosciences, Inc. (PBIO) Starts Presentation at LD Micro Main Event”

Contact us: 212.418.1217